FDA Inspection 730937 — Boston Analytical, Inc.

Boston Analytical, Inc. — FEI 1221426

The FDA completed an inspection of Boston Analytical, Inc. on June 16, 2011 in Salem, NH. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions were found but do not meet the threshold for regulatory action). Product area: Drugs.

Inspection Details

Classification
Voluntary Action Indicated (VAI) (VAI)
End Date
June 16, 2011
Fiscal Year
2011
Product Type
Drugs
Project Area
Drug Quality Assurance
Location
Salem, NH (United States)